The cGAS-STING signaling pathway: emerging targets and challenges in breast cancer immunotherapy

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The cGAS-STING pathway is a critical link between innate and adaptive immunity.
• Its role in breast cancer is complex, influencing both anti-tumor responses and tumor promotion.
• Understanding this pathway is key to developing novel cancer treatments.

Purpose of the Study:

• To review the dual role of the cGAS-STING pathway in the breast tumor microenvironment.
• To explore the therapeutic potential of STING agonists in breast cancer immunotherapy.
• To summarize challenges and future directions for cGAS-STING pathway modulation in breast cancer.

Main Methods:

• Literature review of studies on the cGAS-STING pathway in breast cancer.
• Analysis of the pathway's function in tumor immunology and progression.
• Evaluation of STING agonists as a therapeutic strategy.
• Discussion of clinical translation challenges and potential solutions.

Main Results:

• Pathway activation can either enhance anti-tumor immunity or promote tumor progression via immunosuppression.
• STING agonists can convert non-inflamed tumors into T-cell-inflamed environments.
• Combination therapy with STING agonists shows synergistic potential.
• Significant hurdles exist in translating these findings to clinical practice.

Conclusions:

• The cGAS-STING pathway presents a promising target for breast cancer immunotherapy.
• Overcoming challenges in pathway modulation is crucial for clinical success.
• Future research should focus on rational development of next-generation cGAS-STING-based therapies for breast cancer.